A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran

Objective: The purpose of the present study was a survey of venous thromboembolism (VTE) prophylaxis in obstetrics patients in Iran. Materials and methods: A national, multicenter, non-interventional, prospective study was performed on 1000 women at 11 different parts of Iran. Primary outcome was t...

Full description

Bibliographic Details
Main Authors: Majid Mokhtari, Khadijeh Nasri, Fatemeh Tara, Elahe Zarean, Sedigheh Hantoushzadeh, Mehrnaz Radmehr, Maryam Kashanian
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2019-07-01
Series:Journal of Family and Reproductive Health
Subjects:
Online Access:https://jfrh.tums.ac.ir/index.php/jfrh/article/view/1049
_version_ 1818891017786490880
author Majid Mokhtari
Khadijeh Nasri
Fatemeh Tara
Elahe Zarean
Sedigheh Hantoushzadeh
Mehrnaz Radmehr
Maryam Kashanian
author_facet Majid Mokhtari
Khadijeh Nasri
Fatemeh Tara
Elahe Zarean
Sedigheh Hantoushzadeh
Mehrnaz Radmehr
Maryam Kashanian
author_sort Majid Mokhtari
collection DOAJ
description Objective: The purpose of the present study was a survey of venous thromboembolism (VTE) prophylaxis in obstetrics patients in Iran. Materials and methods: A national, multicenter, non-interventional, prospective study was performed on 1000 women at 11 different parts of Iran. Primary outcome was to assess the situation of VTE prophylaxis in pregnant and postpartum women and the secondary outcome was risk stratification in obstetrics patients and to evaluate the guideline adherence in physician’s practice of VTE prophylaxis. Results: 1,036 women entered the final analysis. The three main VTE risk factors before hospitalization were BMI > 30 kg/m2, history of oral contraceptive (OCP) use, and the age over 35.VTE risk factors upon enrollment were detected in 780 (75.28%) patients. 219 women (28.07%) were deemed eligible for drug prophylaxis, however, only 37 women (17%) received it. A total of 113 (10.9%) patients received VTE prophylaxis, of which 76 (67.25%) women had no clear indications. Concordance between theory and practice was detected with a Cohen’s Kappa coefficient to be 0.74 (p < 0.001), which fell within “good agreement”. Multivariate analysis for association between VTE prophylaxis and VTE risk factors showed that history of VTE [OR = 9.06 (CI 95% 1.16 – 70.8) p = 0.036] was the most frequent risk factor for receiving VTE prophylaxis followed by obesity (BMI > 30 Kg/m2); [OR = 3.74 (CI 95% 1.79 – 5.69), p = <0.001], multiple pregnancy [OR= 2.81 (CI 95% 1.70 – 4.64), p = < 0.001] and age > 35 years; [OR =1.09 (CI 95% 0.82 – 1.21), p = 0.026]. Varicose Veins [OR= 0.22 (CI 95% 0.56 – 0.87), p = 0.031], PROM / PPROM [OR= 0.33 (CI 95% 0.12 – 0.91), p = 0.032] and history of using OCP [OR= 0.36 (CI 95% 0.24 – 0.53), p = < 0.001] were the most missed risk factors for receiving VTE prophylaxis respectively. Conclusion: History of VTE, obesity, multiple pregnancy and age > 35 years were the most frequent risk factors for receiving VTE prophylaxis and varicose veins, PROM / PPROM and history of using OCP were the most missed risk factors for receiving VTE prophylaxis.
first_indexed 2024-12-19T17:34:07Z
format Article
id doaj.art-1daf299c81e3406a886d3cc93e6546c1
institution Directory Open Access Journal
issn 1735-8949
1735-9392
language English
last_indexed 2024-12-19T17:34:07Z
publishDate 2019-07-01
publisher Tehran University of Medical Sciences
record_format Article
series Journal of Family and Reproductive Health
spelling doaj.art-1daf299c81e3406a886d3cc93e6546c12022-12-21T20:12:22ZengTehran University of Medical SciencesJournal of Family and Reproductive Health1735-89491735-93922019-07-0113110.18502/jfrh.v13i1.16091049A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in IranMajid Mokhtari0Khadijeh Nasri1Fatemeh Tara2Elahe Zarean3Sedigheh Hantoushzadeh4Mehrnaz Radmehr5Maryam Kashanian6Department of Internal Medicine, Shahid Beheshti University of Medical Sciences, Imam Hosein Hospital, Tehran, IranDepartment of Obstetrics and Gynecology, Arak University of Medical Sciences, Arak, IranDepartment of Obstetrics and Gynecology, Mashhad University of Medical Sciences, Ommol Banin Teaching Hospital, Mashhad, IranDepartment of Obstetrics and Gynecology, Isfahan University of Medical Sciences, Alzahra Teaching Hospital, Isfahan, IranMaternal-Fetal Medicine Research Center, Tehran University of Medical Sciences, Imam Khomeini Teaching Hospital, Tehran, IranDepartment of Obstetrics and Gynecology, Milad Hospital, Tehran, IranDepartment of Obstetrics and Gynecology, Iran University of Medical Sciences, Akbarabadi Teaching Hospital, Tehran, IranObjective: The purpose of the present study was a survey of venous thromboembolism (VTE) prophylaxis in obstetrics patients in Iran. Materials and methods: A national, multicenter, non-interventional, prospective study was performed on 1000 women at 11 different parts of Iran. Primary outcome was to assess the situation of VTE prophylaxis in pregnant and postpartum women and the secondary outcome was risk stratification in obstetrics patients and to evaluate the guideline adherence in physician’s practice of VTE prophylaxis. Results: 1,036 women entered the final analysis. The three main VTE risk factors before hospitalization were BMI > 30 kg/m2, history of oral contraceptive (OCP) use, and the age over 35.VTE risk factors upon enrollment were detected in 780 (75.28%) patients. 219 women (28.07%) were deemed eligible for drug prophylaxis, however, only 37 women (17%) received it. A total of 113 (10.9%) patients received VTE prophylaxis, of which 76 (67.25%) women had no clear indications. Concordance between theory and practice was detected with a Cohen’s Kappa coefficient to be 0.74 (p < 0.001), which fell within “good agreement”. Multivariate analysis for association between VTE prophylaxis and VTE risk factors showed that history of VTE [OR = 9.06 (CI 95% 1.16 – 70.8) p = 0.036] was the most frequent risk factor for receiving VTE prophylaxis followed by obesity (BMI > 30 Kg/m2); [OR = 3.74 (CI 95% 1.79 – 5.69), p = <0.001], multiple pregnancy [OR= 2.81 (CI 95% 1.70 – 4.64), p = < 0.001] and age > 35 years; [OR =1.09 (CI 95% 0.82 – 1.21), p = 0.026]. Varicose Veins [OR= 0.22 (CI 95% 0.56 – 0.87), p = 0.031], PROM / PPROM [OR= 0.33 (CI 95% 0.12 – 0.91), p = 0.032] and history of using OCP [OR= 0.36 (CI 95% 0.24 – 0.53), p = < 0.001] were the most missed risk factors for receiving VTE prophylaxis respectively. Conclusion: History of VTE, obesity, multiple pregnancy and age > 35 years were the most frequent risk factors for receiving VTE prophylaxis and varicose veins, PROM / PPROM and history of using OCP were the most missed risk factors for receiving VTE prophylaxis.https://jfrh.tums.ac.ir/index.php/jfrh/article/view/1049Venous Thrombo-embolismObstetric PopulationDeep Venous ThrombosisVTE ProphylaxisPulmonary Embolism
spellingShingle Majid Mokhtari
Khadijeh Nasri
Fatemeh Tara
Elahe Zarean
Sedigheh Hantoushzadeh
Mehrnaz Radmehr
Maryam Kashanian
A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran
Journal of Family and Reproductive Health
Venous Thrombo-embolism
Obstetric Population
Deep Venous Thrombosis
VTE Prophylaxis
Pulmonary Embolism
title A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran
title_full A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran
title_fullStr A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran
title_full_unstemmed A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran
title_short A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran
title_sort survey of venous thromboembolism vte prophylaxis in obstetrics patients in iran
topic Venous Thrombo-embolism
Obstetric Population
Deep Venous Thrombosis
VTE Prophylaxis
Pulmonary Embolism
url https://jfrh.tums.ac.ir/index.php/jfrh/article/view/1049
work_keys_str_mv AT majidmokhtari asurveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran
AT khadijehnasri asurveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran
AT fatemehtara asurveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran
AT elahezarean asurveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran
AT sedighehhantoushzadeh asurveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran
AT mehrnazradmehr asurveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran
AT maryamkashanian asurveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran
AT majidmokhtari surveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran
AT khadijehnasri surveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran
AT fatemehtara surveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran
AT elahezarean surveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran
AT sedighehhantoushzadeh surveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran
AT mehrnazradmehr surveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran
AT maryamkashanian surveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran